| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Genmab A/s (GMAB) has 1 insider with recent SEC Form 4 filings, including 11 buys and 0 sells. GMAB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Genmab A/s | 10% Owner | Buy | 76,922,983 | $1.33 | $102,411,048.00 | +110.2% | |
| Dec 26, 2025 | Genmab A/s | 10% Owner | Buy | 815,444 | $97.00 | $79,098,068.00 | +0.3% | |
| Dec 19, 2025 | Genmab A/s | 10% Owner | Buy | 278,441 | $97.00 | $27,008,777.00 | +0.2% | |
| Dec 17, 2025 | Genmab A/s | 10% Owner | Buy | 271,547 | $97.00 | $26,340,059.00 | +0.2% |